MicroRNA expression changes during interferon-beta treatment in the peripheral blood of multiple sclerosis patients M Hecker, M Thamilarasan, D Koczan, I Schröder, K Flechtner, ... International journal of molecular sciences 14 (8), 16087-16110, 2013 | 150 | 2013 |
MicroRNAs in multiple sclerosis and experimental autoimmune encephalomyelitis M Thamilarasan, D Koczan, M Hecker, B Paap, UK Zettl Autoimmunity reviews 11 (3), 174-179, 2012 | 133 | 2012 |
Integration of MicroRNA databases to study MicroRNAs associated with multiple sclerosis C Angerstein, M Hecker, BK Paap, D Koczan, M Thamilarasan, ... Molecular neurobiology 45, 520-535, 2012 | 60 | 2012 |
Multiple sclerosis: modulation of toll-like receptor (TLR) expression by interferon-β includes upregulation of TLR7 in plasmacytoid dendritic cells K Derkow, JMJ Bauer, M Hecker, BK Paap, M Thamilarasan, D Koczan, ... PLoS One 8 (8), e70626, 2013 | 57 | 2013 |
IL-11 induces encephalitogenic Th17 cells in multiple sclerosis and experimental autoimmune encephalomyelitis X Zhang, N Kiapour, S Kapoor, T Khan, M Thamilarasan, Y Tao, S Cohen, ... The Journal of Immunology 203 (5), 1142-1150, 2019 | 44 | 2019 |
STING agonist mitigates experimental autoimmune encephalomyelitis by stimulating type I IFN–dependent and–independent immune-regulatory pathways BM Johnson, T Uchimura, MD Gallovic, M Thamilarasan, WC Chou, ... The Journal of Immunology 206 (9), 2015-2028, 2021 | 24 | 2021 |
Mn Porphyrins as a Novel Treatment Targeting Sickle Cell NOXs to Reverse and Prevent Acute Vaso-Occlusion in Vivo. M Thamilarasan, R Estupinan, I Batinic-Haberle, R Zennadi Blood Advances 4 (Issue 11), 2372–2386, 2020 | 20 | 2020 |
Glatiramer acetate treatment effects on gene expression in monocytes of multiple sclerosis patients M Thamilarasan, M Hecker, RH Goertsches, BK Paap, I Schröder, ... Journal of Neuroinflammation 10, 1-12, 2013 | 20 | 2013 |
Cilia proteins are biomarkers of altered flow in the vasculature A Gupta, K Thirugnanam, M Thamilarasan, AM Mohieldin, HT Zedan, ... JCI Insight, 2022 | 6 | 2022 |
Restoration of Normal Blood Flow in Mouse Models of Sickle Cell Vaso-Occlusion Following Intravenous or Subcutaneous Administration of a Highly Potent E-Selectin Specific Inhibitor M Thamilarasan, WE Fogler, JL Magnani, R Zennadi Blood 136, 17, 2020 | 2 | 2020 |
MicroRNA detection and quantification in human peripheral blood microvesicles from multiple sclerosis patients treated with interferon-beta-1b M Thamilarasan, C Angerstein, B Paap, D Koczan, R Goertsches, ... MULTIPLE SCLEROSIS JOURNAL 17, S500-S501, 2011 | 1 | 2011 |
Dynamic ex vivo monocyte specific and T cell relevant RNA signatures after glatiramer acetate administration in multiple sclerosis G Robert, H Michael, T Madhan, K Dirk, HJ Thiesen, UK Zettl JOURNAL OF NEUROIMMUNOLOGY 228 (1-2), 90-90, 2010 | 1 | 2010 |
Detection and quantification of microRNA expression in human peripheral blood microvesicles from multiple sclerosis patients treated with interferon-beta-1b T Madhan, K Dirk, HG Robert, H Michael, T Hans-Juergen, ZU Klaus JOURNAL OF NEUROIMMUNOLOGY 228 (1-2), 9-9, 2010 | 1 | 2010 |
Ex vivo genome-wide RNA profiling reveals early and consistent transcriptional regulation within two years of interferon beta-1a sc therapy in relapsing-remitting multiple … R Goertsches, M Hecker, M Thamilarasan, D Koczan, HJ Thiesen, ... Multiple Sclerosis 15 (9), S238-S238, 2009 | 1 | 2009 |
Mn Porphyrin-Based Redox Active Drugs Improve Anemia and Reduce Organ Damage in a Murine Model of Sickle Cell Disease M Thamilarasan, R Estupinan, R Zennadi Blood 134, 2255, 2019 | | 2019 |
Teriflunomide inhibits activation and proliferation of B-cells in patients with relapsing remitting multiple sclerosis (RRMS) S Markovic-Plese, M Thamilarasan, X Zhang MULTIPLE SCLEROSIS JOURNAL 25, 303-304, 2019 | | 2019 |
Mn Porphyrin-Based Redox Active Drugs As Novel Anti-Adhesive and Anti-Inflammatory Agents Targeting Sickle Red Blood Cell Oxidative Damage In Vivo T Madhan, R Estupinan, R Zennadi Blood 132, 270, 2018 | | 2018 |
Expansion of Tregs mediates Murine (m) aCD52 mAb suppression of experimental autoimmune encephalomyelitis (EAE) N Kiapoor, B Wu, S Kapoor, X Zhang, M Thamilarasan, Y Wan, ... MULTIPLE SCLEROSIS JOURNAL 24, 1021-1021, 2018 | | 2018 |
Teriflunomide inhibits activation and proliferation of B-cells in patients with relapsing remitting multiple sclerosis (RRMS) M Thamilarasan, X Zhang, S Markovic-Plese MULTIPLE SCLEROSIS JOURNAL 23, 857-858, 2017 | | 2017 |
IL-11 induces encephalitogenic Th17 cells N Kiapour, X Zhang, TH Khan, M Thamilarasan, S Kapoor, ... The Journal of Immunology 198 (1_Supplement), 210.11-210.11, 2017 | | 2017 |